The Dawn of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease, presented by Akram Audi, MD, Nephrology Fellow, Department of Medicine, Division of Nephrology, and Rickinder Grewal, MD, Nephrology Fellow, Department of Medicine, Division of Nephrology, Both: University of Rochester Medical Center.
At the conclusion of this presentation participants should be able to:
1. Understand the pathophysiology and disease course of autosomal dominant polycystic kidney disease.
2. Understand the indications for tolvaptan in autosomal dominant polycystic kidney disease as well as potential adverse events.
The University of Rochester School of Medicine and Dentistry designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Tuesday, February 26, 2019 at 12:00pm to 1:00pm
Class of '62 Auditorium
601 Elmwood Avenue, Rochester, NY 14642